Mixed Reports on FDA Efficacy
Submitted by Judith Siers-Poisson on
The number of warning letters sent by the U.S. Food and Drug Administration to corporations has dropped by 50% in the last decade. In 2002, the regulatory agency decided that all warning letters should go through the office of its chief counsel, a move "designed to strengthen the letters and make them legally consistent and credible." But the change may have just succeeded in slowing the process to a crawl.